186 related articles for article (PubMed ID: 9717810)
1. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM
Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
[TBL] [Abstract][Full Text] [Related]
4. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
5. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
6. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activators and their inhibitor in osteosarcomas and other bone tumors.
Häkel C; Ueda Y; Tsuchya H; Herrera A; Blasius S; Roessner A
Zentralbl Pathol; 1994 Nov; 140(4-5):363-9. PubMed ID: 7826985
[TBL] [Abstract][Full Text] [Related]
8. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
Holt SV; Brookes KE; Dive C; Makin GW
Oncol Rep; 2011 Apr; 25(4):1177-81. PubMed ID: 21286665
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; García-Echeverría C; Hofmann F; Picci P
Cancer Res; 2005 May; 65(9):3868-76. PubMed ID: 15867386
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic studies on fine-needle aspiration samples from osteosarcoma and Ewing's sarcoma.
Akerman M; Dreinhöfer K; Rydholm A; Willén H; Mertens F; Mitelman F; Mandahl N
Diagn Cytopathol; 1996 Jul; 15(1):17-22. PubMed ID: 8807247
[TBL] [Abstract][Full Text] [Related]
12. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.
Garg V; Zhang W; Gidwani P; Kim M; Kolb EA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5446-54. PubMed ID: 17875774
[TBL] [Abstract][Full Text] [Related]
13. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of PP1gamma1, a catalytic subunit isoform of protein phosphatase type1 and expression of telomerase activity in Ewing's sarcoma cells.
Mori S; Cao Y; Yamadab T; Sogawa K; Kondo K; Hino N; Miyazaki T; Kawaguchi Y; Oka S; Kawasaki K; Mashiba T; Norimatsu H
Res Commun Mol Pathol Pharmacol; 2003; 113-114():269-74. PubMed ID: 15686125
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma.
Kontny HU; Lehrnbecher TM; Chanock SJ; Mackall CL
Cancer Res; 1998 Dec; 58(24):5842-9. PubMed ID: 9865744
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in pediatric sarcomas.
Dickens DS; Kozielski R; Khan J; Forus A; Cripe TP
Pediatr Dev Pathol; 2002; 5(4):356-64. PubMed ID: 12024286
[TBL] [Abstract][Full Text] [Related]
18. Procollagens as markers for the cell of origin of human bone tumors.
Stern R; Wilczek J; Thorpe WP; Rosenberg SA; Cannon G
Cancer Res; 1980 Feb; 40(2):325-8. PubMed ID: 6927962
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
20. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
Halmos G; Schally AV; Bernardino AL; Varga JL
Int J Oncol; 2006 Aug; 29(2):463-9. PubMed ID: 16820890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]